This event will focus on the topic of “Design Thinking”. Some of the world’s leading brands, such as Apple, Google, Samsung, and GE, have rapidly adopted the Design Thinking approach and Design Thinking is being taught at leading universities around the world, including Stanford, Harvard and MIT. Design thinking is an methodology that provides a solution-based approach to solving problems. It’s extremely useful in tackling complex problems that are ill-defined or unknown, by understanding the human needs involved, by re-framing the problem in human-centric ways, by creating many ideas in brainstorming sessions, and by adopting a hands-on approach in prototyping and testing. Alexander Boll will present insights into the design thinking process and application of this methodology. He obtained a degree in Business Administration from LIMAK -Austrian Business School and is currently Innovation Manager at Haufe group. This event is also in collaboration with women ++ , a Swiss non-profit organization that strives to increase diversity in tech. Following his presentations, you will have the chance to discuss more with Alexander over the networking apéro. Please register on our website: https://bsse-industry.ethz.ch If you are not affiliated with any Swiss university anymore and would like to register for this event, please e-mail us via bsse-industry@bsse.ethz.ch.

Coming up soon again.

For our first event of 2018 we joined forces with the Graduate Consulting Club and are delighted to host KPMG. The sheer amount of data generated by new tools is not only an opportunity and challenge in the scientific world but will also change the face of some industries. In this talk by KPMG you will learn more about the company and the way healthcare consulting might change in an age of big data analytics & AI. Below the key points: - Big Data and AI - What’s KPMG’s view on the life science industry in 2030 - How KPMG helps clients transform their business processes - Healthcare goes mobile Speakers/KPMG representatives will include: - Claudio Boller, Head of Audit Basel and Regional Market Leader - Martin Rohrbach, Head of Life Sciences - Alberto Zampella, Assurance Technology Group - Robin Wirz, KPMG Mobile Solutions (former CEO Terria Mobile) Following the talk, you will have the opportunity to talk some more to the speakers during our networking apéro. Please register on our website: https://bsse-industry.ethz.ch/events/kpmg-the-future-of-healthcare-consulting/

Picuters of our last event this year hosting Michael Hübner from Roche working in Business Development and Licensing.

Are you interested in deal making, business development and licensing? Then attend our next on-site event hosting Michael Huebner working at Roche as Global Business Development & Licensing (BD&L) Associate Oncology. Before joining Roche over three years ago, he obtained his PhD in Heidelberg (EMBL) and worked as a research fellow in the US (CSHL). He will talk about his career path, his job and feeling the pulse of cancer therapy with all its latest trends. Following his presentations, you will have the chance to discuss more with Michael over the networking apéro. For registration, please visit our website: https://bsse-industry.ethz.ch/events/michael-huebner-and-the-art-of-the-deal/ If you are not affiliated with any Swiss university anymore and would like to register for this event, please e-mail us directly (bsse-industry[at]bsse.ethz.ch).

We host this event together with ETHZ's iGEM Team. Dr. Simon Ittig, CEO and co-founder of T3 Pharmaceuticals completed a PhD on microbial pathogenesis at the University of Basel. He started working on the T3 Pharma technology during his post-doctoral studies at the Biozentrum. In 2015, he and his co-workers decided to develop the technology further to bring it into clinics. T3 Pharmaceuticals is a pre-clinical biopharmaceutical company working to advance new generation therapies for cancer patients as a spin-off of University of Basel. The team has developed an efficient protein delivery technology that is based on the use of live bacteria. While the technology has diverse applications in research, T3 Pharma has further developed the system to serve as a novel therapeutic to treat solid tumors. The idea to treat cancer by the use of live bacteria has also been taken up by this year’s ETHZ iGEM team. In a short talk they will present what they have in mind to deliver a drug in a controllable and safe manner to treat tumors. The talk will be followed by an apéro where you can talk some more to Simon Ittig as well as to our ETHZ iGEM team. Make sure to book your spot via our website (or if you are not affiliated to a university anymore, to let us know via e-mail: bsse-industry@bsse.ethz.ch)

Our Clariant talk was featured on the company's Linkedin page & Twitter 🎉 https://www.linkedin.com/feed/update/urn:li:activity:6313696962214400000 https://twitter.com/clariant/status/907932242848006144

D-BSSE meets Industry and the ETHZ Biotech Alumni organization invite you to the second annual D-BSSE Alumni Event. The event aims at synergizing our common interests to help connect current D-BSSE members with D-BSSE Alumni now working in industry. This year, it will be of particular magnitude, as we will also celebrate the 10th anniversary of our department. Spend an evening discussing science, innovation, possible career options, and many other topics and join us in our effort to strengthen the ties of the D-BSSE Alumni network further! Program overview: 19:00 - Introduction of D-BSSE meets Industry, the ETHZ Biotech Alumni Organization and the VMB 19:15 - Short greeting from Prof. Niko Beerenwinkel and new department image video 19:20 - Three short talks of selected D-BSSE Alumni: Marc Gitzinger (CEO of Bioversys) Juliane Siebourg (Senior Biostatician at Roche) Sebastian Bürgel (co-founder and CTO of Validity Labs) 20:10 - General open question panel 20:30 to 22:00 - Networking Apéro This event is open to anyone from the Basel Life Science community, as we’d also like to kindly invite our friends. Please register here https://bsse-industry.ethz.ch/events/d-bsse-meets-its-alumni-2017/ or if you are not affiliated with the D-BSSE or another university anymore and would like to register, please e-mail us (bsse-industry[at]bsse.ethz.ch) and let us know what your current position and employer are. You can book a +1 if you like, just let us know the name (and position/employer) via the booking comments field or e-mail. Thanks to generous support from our department, we are able to welcome you at Launchlabs this year!

Dr. Ralf Hortsch, head of operations biofuels & derivatives at Clariant, will present his career and current work at Clariant in Munich. Ralf is working for the Sunliquid project and will therefore give you an insight into how straw and other agricultural waste material can be effectively transformed into fuel. Indeed, shortage of fossil resources, energy security, climate change, environmental protection are the issues concerning us today in the energy sector. Alternative sources of energy must be found to reduce our dependence on oil and nowhere is this more evident than in the transport sector. In the European Union, the US and other major economic areas, politicians have laid down basic frameworks to promote the use of climate-friendly biofuels. Our guest Dr. Ralf Hortsch from Clariant will talk about the sunliquid process and elucidate the great challenges and future perspectives of second generation biofuel production. He will be accompanied by Dr. Jochen Dubiel, head of corporate communiations, and Anne Maier, Manager of corporate & GTI communications at Clariant in Switzerland. They will both be at the networking apéro following Ralf’s talk to answer additional questions about Clariant. For registration, please visit our website: https://bsse-industry.ethz.ch/events/sunliquid-and-a-career-at-clariant/